CLL
From the Journals
‘Agony of choice’ for clinicians treating leukemia
Novel targeted therapies emerge as frontline options while chemoimmunotherapy “fades into the background.”
From the Journals
Study: COVID immunity transferable through HSCT
A small French study seems to confirm that vaccinating donors against SARS-CoV-2 before hematopoietic stem-cell transplant significantly boosts...
Conference Coverage
Zanubrutinib shows worth against standard CLL drugs
New CLL drug demonostrates its efficacy in the crowded field of CLL treatment options.
Feature
When CPI fails, HL patients should get timely allo-HCT
New data suggest that physicians should refer Hodgkin lymphoma patients for allogeneic HCT without delay when PD-1 treatments fail.
Feature
Survivor’s story foreshadows one of oncology’s greatest successes
In 1992, a young New Yorker was among the first Hodgkin lymphoma patients to undergo a successful bone marrow transplant. Three decades later,...
From the Journals
Some leukemias detectable up to 16 years before diagnosis?
Sequencing analysis showed that even high-risk CLL subtypes precursor states may exist up to 16 years longer than previously thought.
Commentary
A little-known offshoot of hem/onc opens pathway for professional development
Among hematologist oncologists, discussion and research is underway on how we evaluate and treat vascular anomalies--a fertile area for...
From the Journals
Eating olive oil may slow CLL disease progression
A pilot study in Greece suggested that consuming extra virgin olive oil daily induced the apoptosis of cancer cells.
Feature
Repurposed drug could revolutionize stem cell transplantation
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...
From the Journals
Hodgkin-directed therapy may benefit patients with rare CLL subtype
Patients diagnosed with an uncommon subtype of chronic lymphocytic lymphoma show improved outcomes from Hodgkin-directed treatments.
From the Journals
9/11 first responders show mutations linked to blood cancers
Blood samples from firefighters and emergency workers at Ground Zero show higher burden of clonal hematopoiesis, suggesting need for mutational...